CDH1 and cancer: The EMT is a reversible physiological process involved in cancer progression via the morphological repression of epithelial markers (e.g., E-cadherin, claudins, occludins) and acquiring of mesenchymal markers (e.g., vimentin, fibronectin, N-cadherin) [6].